From February 21st to 23rd, 2024, the 24th annual meeting of Yabuli China Entrepreneurs Forum was held in Heilongjiang.At the Great Health Forum held on the afternoon of February 22, Yang Zhe, chairman of Taihe Huamei (Beijing) Pharmaceutical Technology Co., Ltd. attended and spoke.
Yang Zhe said that Taihe Huamei is currently mainly developing the research and development of innovative drugs, and is mainly targeted at targeted drugs and autoimmune diseasesdirection.
Yang Zhe said, "An accidental opportunity company pays attention to Grave Frozen the previous year.More academics and papers are guided in this regard. We have done a lot of research clinical clinical clinical, including Cai Lei, who are more well -known patients with gradients, and recruited patients from July 2022. Through preliminary scientific research on nearly 100 people临床我们找到了一些有可能的规律，也看到了一些潜在的疗效。”
他称，我们想自身免疫病这条路先从渐冻症入手，因为渐As a rare disease, if you can have a certain breakthrough, you can expand to other diseases.family
